TGFBR1 and carcinoma: The Tgfbr1/Pten 2cKO mice were therefore tested with IL-13-PE (50 μg/kg b.i.d. on alternate days) for two weeks starting at an early point in tumor induction when carcinomas are first beginning to appear.